These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32814005)

  • 1. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports.
    Salvador JG; Bhatt SR; Jacobsohn VC; Maley LA; Alkhafaji RS; Rishel Brakey H; Myers OB; Sussman AL
    Subst Abus; 2021; 42(4):610-617. PubMed ID: 32814005
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.
    Salvador JG; Myers OB; Bhatt SR; Jacobsohn V; Lindsey L; Alkhafaji RS; Rishel Brakey H; Sussman AL
    Subst Abus; 2023 Oct; 44(4):282-291. PubMed ID: 37902036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
    Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
    J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmenting project ECHO for opioid use disorder with data-informed quality improvement.
    Murray OB; Doyle M; McLeman BM; Marsch LA; Saunders EC; Cox KM; Watts D; Ryer J
    Addict Sci Clin Pract; 2023 Apr; 18(1):24. PubMed ID: 37106399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
    Shea CM; Gertner AK; Green SL
    Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.
    Tofighi B; Isaacs N; Byrnes-Enoch H; Lakew R; Lee JD; Berry C; Schatz D
    J Subst Abuse Treat; 2019 Nov; 106():1-3. PubMed ID: 31540604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities.
    Hawkins EJ; Danner AN; Malte CA; Blanchard BE; Williams EC; Hagedorn HJ; Gordon AJ; Drexler K; Burden JL; Knoeppel J; Lott A; Sayre GG; Midboe AM; Saxon AJ
    Addict Sci Clin Pract; 2021 Sep; 16(1):55. PubMed ID: 34488892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America.
    Cole ES; DiDomenico E; Green S; Heil SKR; Hilliard T; Mossburg SE; Sussman AL; Warwick J; Westfall JM; Zittleman L; Salvador JG
    Subst Abus; 2021; 42(2):123-129. PubMed ID: 33689594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study.
    Poulsen MN; Roe SA; Asdell PB; Rahm AK; Berrettini W
    J Subst Use Addict Treat; 2024 Mar; 158():209250. PubMed ID: 38072381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations.
    McLeman B; Gauthier P; Lester LS; Homsted F; Gardner V; Moore SK; Joudrey PJ; Saldana L; Cochran G; Harris JP; Hefner K; Chongsi E; Kramer K; Vena A; Ottesen RA; Gallant T; Boggis JS; Rao D; Page M; Cox N; Iandiorio M; Ambaah E; Ghitza U; Fiellin DA; Marsch LA
    Addict Sci Clin Pract; 2024 Mar; 19(1):18. PubMed ID: 38500166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder.
    Robles M; Mortazavi L; Vannerson J; Matthias MS
    Teach Learn Med; 2022; 34(5):514-521. PubMed ID: 33974460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
    Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
    J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care.
    Chang ET; Oberman RS; Cohen AN; Taylor SL; Gumm E; Mardian AS; Toy S; Revote A; Lewkowitz B; Yano EM
    J Gen Intern Med; 2020 Dec; 35(Suppl 3):918-926. PubMed ID: 33145686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study.
    Hser YI; Mooney LJ; Baldwin LM; Ober A; Marsch LA; Sherman S; Matthews A; Clingan S; Fei Z; Zhu Y; Dopp A; Curtis ME; Osterhage KP; Hichborn EG; Lin C; Black M; Calhoun S; Holtzer CC; Nesin N; Bouchard D; Ledgerwood M; Gehring MA; Liu Y; Ha NA; Murphy SM; Hanano M; Saxon AJ
    J Rural Health; 2023 Sep; 39(4):780-788. PubMed ID: 37074350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care.
    Sussman AL; Crawford JN; Brakey HR; Alkhafaji RS; Myers OB; Jacobsohn V; Bhatt S; Salvador J
    J Am Board Fam Med; 2021; 34(6):1216-1220. PubMed ID: 34772777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
    Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
    Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain.
    Chapman SA; Fraimow-Wong L; Phoenix BJ; Tierney M; Spetz J
    J Subst Use Addict Treat; 2024 Feb; 157():209215. PubMed ID: 37979946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
    Bridges NC; Taber R; Foulds AL; Bear TM; Cloutier RM; McDonough BL; Gordon AJ; Cochran GT; Donohue JM; Adair D; DiDomenico E; Pringle JL; Gellad WF; Kelley D; Cole ES
    J Subst Use Addict Treat; 2023 Nov; 154():209133. PubMed ID: 37543217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.